Annual Drug Patent Expirations for DEFINITY
Definity is a drug marketed by Lantheus Medcl and is included in one NDA. There are four patents protecting this drug.
This drug has forty-two patent family members in fourteen countries.
The generic ingredient in DEFINITY is perflutren. Additional details are available on the perflutren profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
